NCA Publications

New NCA Publications

Sort by: Date | Author | Title

Karlsson, P., Sjogaard, M. B., Schousboe, K., Mizrak, H. I., Kufaishi, H., Staehelin Jensen, T., Randel Nyengaard, J., Hansen, C. S., Yderstræde, K. B. & Buhl, C. S. (2024). Assessment of neuropathy subtypes in type 1 diabetes. BMJ Open Diabetes Research & Care, 12(4), Article e004289. https://doi.org/10.1136/bmjdrc-2024-004289
Santos, J., Cuellar, J., Pallarès, I., Byrd, E. J., Lends, A., Moro, F., Abdul-Shukkoor, M. B., Pujols, J., Velasco-Carneros, L., Sobott, F., Otzen, D. E., Calabrese, A. N., Muga, A., Pedersen, J. S., Loquet, A., Valpuesta, J. M., Radford, S. E. & Ventura, S. (2024). A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion. Journal of the American Chemical Society, 146(18), 12702-12711. https://doi.org/10.1021/jacs.4c02262
Vieira de Sá, R., Sudria-Lopez, E., Cañizares Luna, M., Harschnitz, O., van den Heuvel, D. M. A., Kling, S., Vonk, D., Westeneng, H. J., Karst, H., Bloemenkamp, L., Varderidou-Minasian, S., Schlegel, D. K., Mars, M., Broekhoven, M. H., van Kronenburg, N. C. H., Adolfs, Y., Vangoor, V. R., de Jongh, R., Ljubikj, T. ... Pasterkamp, R. J. (2024). ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes. Nature Communications, 15(1), Article 7484. https://doi.org/10.1038/s41467-024-51676-0
Otzen, D. & d'Angelo, J. (2024). BBA: 2024 and beyond. Biochimica et Biophysica Acta - General Subjects, 1868(2), Article 130524. https://doi.org/10.1016/j.bbagen.2023.130524
Pirhaghi, M., Mamashli, F., Moosavi-Movahedi, F., Arghavani, P., Amiri, A., Davaeil, B., Mohammad-Zaheri, M., Mousavi-Jarrahi, Z., Sharma, D., Langel, Ü., Otzen, D. E. & Saboury, A. A. (2024). Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases. Molecular Pharmaceutics, 21(5), 2097-2117. https://doi.org/10.1021/acs.molpharmaceut.3c01167
Carramolino, L., Albarrán-Juárez, J., Markov, A., Hernández-SanMiguel, E., Sharysh, D., Cumbicus, V., Morales-Cano, D., Labrador-Cantarero, V., Møller, P. L., Nogales, P., Benguria, A., Dopazo, A., Sanchez-Cabo, F., Torroja, C. & Bentzon, J. F. (2024). Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes. Nature Cardiovascular Research, 3(2), 203-220. https://doi.org/10.1038/s44161-023-00412-w
Rybiczka-Tešulov, M., Garritsen, O., Venø, M. T., Wieg, L., Dijk, R. V., Rahimi, K., Gomes-Duarte, A., Wit, M. D., van de Haar, L. L., Michels, L., van Kronenburg, N. C. H., van der Meer, C., Kjems, J., Vangoor, V. R. & Pasterkamp, R. J. (2024). Circular RNAs regulate neuron size and migration of midbrain dopamine neurons during development. Nature Communications, 15(1), Article 6773. https://doi.org/10.1038/s41467-024-51041-1
Scoyni, F., Sitnikova, V., Giudice, L., Korhonen, P., Trevisan, D. M., Hernandez de Sande, A., Gomez-Budia, M., Giniatullina, R., Ugidos, I. F., Dhungana, H., Pistono, C., Korvenlaita, N., Välimäki, N. N., Kangas, S. M., Hiltunen, A. E., Gribchenko, E., Kaikkonen-Määttä, M. U., Koistinaho, J., Ylä-Herttuala, S. ... Malm, T. (2024). ciRS-7 and miR-7 regulate ischemia-induced neuronal death via glutamatergic signaling. Cell Reports, 43(3), Article 113862. https://doi.org/10.1016/j.celrep.2024.113862